Status:
RECRUITING
Ocular Complications of Mpox in the Democratic Republic Congo
Lead Sponsor:
Institute of Tropical Medicine, Belgium
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
Conditions:
Monkeypox
Mpox (Monkeypox)
Eligibility:
All Genders
Brief Summary
This is an observational study in which patients diagnosed with mpox will be enrolled, will undergo standard ophthalmological examinations of their eyes to see if there are any complications of mpox. ...
Detailed Description
This is an observational study in which patients diagnosed with mpox will be enrolled in two clinics in remote settings in the DR Congo (Tunda and Kole general hospital) where mpox outbreaks are ongoi...
Eligibility Criteria
Inclusion
- Patient of any age or gender with laboratory-confirmed infection with MPXV
- Laboratory confirmation of MPXV infection less than 48 hours before inclusion
- Patient or culturally acceptable representative is willing and able to give informed consent or assent for participation in the study
Exclusion
- Patients for whom, in the judgment of the recruiting physician, participation in the study would interfere with routine optimal clinical care.
Key Trial Info
Start Date :
October 28 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 29 2025
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT06579885
Start Date
October 28 2024
End Date
June 29 2025
Last Update
November 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kamituga General Hospital
Kamituga, South Kivu, Democratic Republic of the Congo